Dissociation of sensitivities to tumor promotion and progression in outbred and inbred SENCAR mice.

The sensitivity of outbred SENCAR mice and inbred SENCAR (SSIN) mice to multistage carcinogenesis was studied. Tumors were induced using either 7,12-dimethylbenz[a]anthracene or N-methyl-N'-nitro-N-nitrosoguanidine as initiators and 12-O-tetradecanoylphorbol-13-acetate or benzoyl peroxide as promoting agents. Although the number of papillomas per mouse was higher in SSIN than in outbred SENCAR mice, the number of carcinomas observed in the SSIN strain was significantly lower regardless of the initiator or promoter used. It was also observed that the expression of markers of premalignant progression (i.e., dysplasia, expression of keratin K13, and loss of keratin K1 expression) was markedly suppressed in SSIN papillomas. After 50 wk of promotion with 12-O-tetradecanoylphorbol-13-acetate, the pattern of expression of K13 and K1 in SSIN mice was comparable to the pattern observed in outbred SENCAR mice after 10 to 20 wk of promotion with 12-O-tetradecanoylphorbol-13-acetate. It was also observed that 67% of the tumors induced in SSIN mice by initiation with 7,12-dimethylbenz[a]anthracene exhibited a mutation in codon 61 of the Ha-ras-1 gene. This latter finding suggests that the differences observed in tumor progression between the inbred strain and the outbred stock are not related to a genetic alteration in the Ha-ras-1 gene but rather to an independent event that we have postulated to involve a putative suppressor gene. The data reported here suggest that the putative gene(s) that confers susceptibility to tumor promotion was segregated from the gene(s) involved in tumor progression during selection and inbreeding of the SENCAR mouse stock.

[1]  C. Conti,et al.  Overlapping loss of heterozygosity by mitotic recombination on mouse chromosome 7F1-ter in skin carcinogenesis. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[2]  J. DiGiovanni,et al.  Evidence for a common genetic pathway controlling susceptibility to mouse skin tumor promotion by diverse classes of promoting agents. , 1991, Cancer research.

[3]  C. Conti,et al.  Promoter independence as a feature of most skin papillomas in SENCAR mice. , 1991, Cancer research.

[4]  C. Marshall.  Tumor suppressor genes , 1991, Cell.

[5]  C. Conti,et al.  Detection of loss of heterozygosity in formalin-fixed paraffin-embedded tumor specimens by the polymerase chain reaction. , 1991, The American journal of pathology.

[6]  T. Slaga,et al.  Early expression of type I K13 keratin in the progression of mouse skin papillomas. , 1990, Carcinogenesis.

[7]  C. Conti,et al.  Nonrandom duplication of the chromosome bearing a mutated Ha-ras-1 allele in mouse skin tumors. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[9]  A. Balmain,et al.  Genetic changes in skin tumor progression: Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7 , 1990, Cell.

[10]  E. Stanbridge.  Identifying tumor suppressor genes in human colorectal cancer. , 1990, Science.

[11]  T. Slaga,et al.  Sequential trisomization of chromosomes 6 and 7 in mouse skin premalignant lesions , 1989, Molecular carcinogenesis.

[12]  T. Slaga,et al.  Sequential development of aneuploidy, keratin modifications, and gamma-glutamyltransferase expression in mouse skin papillomas. , 1988, Cancer research.

[13]  D. Roop,et al.  Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis. , 1988, Cancer research.

[14]  M. Rentrop,et al.  Aberrant expression during two‐stage mouse skin carcinogenesis of a type 147‐kDa keratin, k13, normally associated with terminal differentiation of internal stratified epithelia , 1988, Molecular carcinogenesis.

[15]  T. Slaga,et al.  Progressive dysplasia and aneuploidy are hallmarks of mouse skin papillomas: relevance to malignancy. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Slaga,et al.  Characterization of an inbred strain of the SENCAR mouse that is highly sensitive to phorbol esters. , 1987, Carcinogenesis.

[17]  T. Slaga,et al.  Aneuploidy, an early event in mouse skin tumor development. , 1986, Carcinogenesis.

[18]  A. Skalka,et al.  Mutagenesis of the Ha-ras oncogene in mouse skin tumors induced by polycyclic aromatic hydrocarbons. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Lowy,et al.  An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue , 1986, Nature.

[20]  S. Yuspa,et al.  Induction of papillomas with a high probability of conversion to malignancy. , 1985, Carcinogenesis.

[21]  P. Steinert,et al.  The Use of cDNA Clones and Monospecific Antibodies as Probes to Monitor Keratin Gene Expression , 1985, Annals of the New York Academy of Sciences.

[22]  P. Steinert,et al.  Synthetic peptides corresponding to keratin subunits elicit highly specific antibodies. , 1984, The Journal of biological chemistry.